Position in PTCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,045,002
+$3,045,002 QoQ
Shares Held
44,694
Ownership
0.054%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Derivatives in PTCT
reported options exposure · as of Sep 30, 2023CallValue
$683,505
CallShares
30,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MOORE CAPITAL MANAGEMENT, LP holds $51,235,346 across 22 Biotechnology names. PTCT ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMCR |
Immunocore Holdings plc
|
197,308 | $5,948,836 | |
| 2 | GMAB |
Genmab A/S
|
211,705 | $5,680,045 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
55,600 | $5,407,100 | |
| 4 | IRON |
Disc Medicine, Inc.
|
57,796 | $3,695,476 | |
| 5 | ATAI |
AtaiBeckley Inc.
|
952,380 | $3,371,425 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
157,132 | $3,291,915 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
This page
|
44,694 | $3,045,002 | |
| 8 | REPL |
Replimune Group, Inc.
|
311,124 | $2,380,098 |
All Filings in PTCT
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,045,002 | 44,694 | Shares | Sole | 2026-05-15 | |
| 2023-09-30 | $683,505 | 30,500 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $1,016,750 | 25,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,380,540 | 28,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,145,100 | 30,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,004,000 | 20,000 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,602,400 | 40,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,492,400 | 40,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,593,200 | 40,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,488,400 | 40,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,690,800 | 40,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,894,000 | 40,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,537,139 | 41,572 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,337,500 | 50,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,029,600 | 40,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,784,400 | 40,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||